[HTML][HTML] Advances in targeted therapy for pancreatic cancer

L Xing, L Lv, J Ren, H Yu, X Zhao, X Kong… - Biomedicine & …, 2023 - Elsevier
Pancreatic cancer (PC) represents a group of malignant tumours originating from pancreatic
duct epithelial cells and acinar cells, and the 5-year survival rate of PC patients is only …

Ocular surface toxicities associated with modern anticancer therapies

R Boucher, O Haigh, E Barreau, S Champiat… - Survey of …, 2023 - Elsevier
Cancer treatments have recently shifted from broad-spectrum cytotoxic therapies to more
focused treatments, maximizing anti-cancerous activity while reducing toxicity to healthy …

[HTML][HTML] Xihuang pill induces pyroptosis and inhibits progression of breast cancer cells via activating the cAMP/PKA signalling pathway

C Chen, S Yuan, X Chen, J Xie… - American Journal of …, 2023 - ncbi.nlm.nih.gov
Xihuang pill (XHP), a traditional Chinese medicine, has been shown to be effective for
breast cancer (BC) therapy in clinical trials. However, the molecular mechanism of XHP in …

Highlights on ocular toxicity of immune checkpoint inhibitors at a US tertiary cancer center

AA Mazharuddin, AT Whyte… - Journal of …, 2022 - meridian.allenpress.com
ABSTRACT Introduction Immune checkpoint inhibitors (ICIs) have improved prognosis in
advanced malignancies; however, they may be associated with extensive ocular immune …

Marine algae‐derived characterized bioactive compounds as therapy for cancer: A review on their classification, mechanism of action, and future perspectives

W Liao, Y Chen, S Shan, Z Chen, Y Wen… - Phytotherapy …, 2024 - Wiley Online Library
In 2022, there were around 20 million new cases and over 9.7 million cancer‐related deaths
worldwide. An increasing number of metabolites with anticancer activity in algae had been …

Interaction of systemic drugs causing ocular toxicity with organic cation transporter: an artificial intelligence prediction

M Malani, MS Hiremath, S Sharma… - Journal of …, 2024 - Taylor & Francis
Chronic disease patients (cancer, arthritis, cardiovascular diseases) undergo long-term
systemic drug treatment. Membrane transporters in ocular barriers could falsely recognize …

Ocular side effects of oncological therapies

M Asencio-Durán, E Fernández-Gutiérrez… - Archivos de la Sociedad …, 2023 - Elsevier
With the advance of cancer therapy in recent years, the knowledge of the mechanisms
involved in this disease has increased, which has meant an increase in the quality of life and …

Клинические проявления и механизмы развития поражения глаз при гемобластозах

НЮ Юсеф, ЕН Мисюрина, ДВ Анджелова… - …, 2023 - ophthalmojournal.com
Аннотация В статье рассмотрены различные офтальмологические проявления при
гемобластозах. Представлено подробное описание наиболее распространенных …

Efectos secundarios oculares de las terapias oncológicas. Revisión

M Asencio-Durán, E Fernández-Gutiérrez… - Archivos de la Sociedad …, 2023 - Elsevier
Con el avance de la terapia contra el cáncer en los últimos años, ha aumentado el
conocimiento de los mecanismos involucrados en esta enfermedad, lo que ha supuesto un …

Histological influence of pembrolizumab on the cornea of adult male albino rats, and the efficacy of topically applied axitinib with and without high albumin level in …

H El-Haroun, N Abd El Bary… - Egyptian Journal of …, 2023 - journals.ekb.eg
Introduction: Immune checkpoint inhibitor (ICI) therapy has revolutionized the treatment of a
wide variety of malignancies. The toxic effects of ICIs can manifest themselves in a variety of …